Existential Genomics: Effects of Multimodal Rehabilitation and Integrative Care on Patients With Chronic Pain
Unknown statusNCT02459639
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Using a comprehensive prospective clinical study design, the investigators intend to compare changes in health-related markers in patients with chronic widespread pain (CWP), undergoing one of two intervention "packages" of multimodal health care, namely anthroposophical integrative care (AIC) or standard care (SC), respectively. AIC combines evidence-based conventional care with complementary/alternative (CAM) treatments. As markers, the investigators will use indicators of drug utilization and sick leave, as well as constructs mirroring possible changes in psychological and existential factors and genomic stability (such as telomere length and telomerase levels).
Study details
- Official title
- Existential Genomics (ExiGence): Effects of Multimodal Rehabilitation and Integrative Care on Pain, Quality of Life, and Genomic Stability in Patients With Chronic Pain
- Conditions
- Interventions
- Other: Anthroposophic integrative care rehabilitation program
- Other: Conventional multi-modal care rehabilitation
- Sponsor
- The Integrative Care Science Center
- Collaborators
- University Hospital, Linkoeping; Ekhagastiftelsen
- Start date
- 2015-06
- Primary completion
- 2017-05
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Pain patients with a primary diagnosis corresponding to ICD-10 M79, or long-term pain for a period of over 3 months in neck/shoulders and/or low back, or generalised pain, * fluency in Swedish and * allowing for co-morbidity/ multiple secondary diagnoses. Exclusion Criteria: * Psychotic illness, * schizophrenia, * bipolar disorder, * substance dependency problems, and * cancer.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02459639